Importance of QT/RR hysteresis correction in studies of drug-induced QTc interval changes

被引:0
作者
Marek Malik
Christine Garnett
Katerina Hnatkova
Lars Johannesen
Jose Vicente
Norman Stockbridge
机构
[1] National Heart and Lung Institute,Division of Cardiovascular and Renal Products
[2] Imperial College,Division of Clinical Pharmacology I, Office of Clinical Pharmacology
[3] Office of New Drugs,undefined
[4] Center for Drug Evaluation and Research,undefined
[5] US Food and Drug Administration,undefined
[6] Center for Drug Evaluation and Research,undefined
[7] US Food and Drug Administration,undefined
来源
Journal of Pharmacokinetics and Pharmacodynamics | 2018年 / 45卷
关键词
QT/RR adaptation; QT/RR hysteresis; QTc interval; Heart rate correction; PK/PD modeling; Statistical simulation;
D O I
暂无
中图分类号
学科分类号
摘要
QT/RR hysteresis and QT/RR adaptation are interlinked but separate physiological processes signifying how quickly and how much QT interval changes when heart rate changes, respectively. While QT interval duration is, as a rule, corrected for heart rate in terms of the QT/RR adaptation, the correction for QT/RR hysteresis is frequently omitted in studies of drug-induced QTc changes. This study used data from previously conducted thorough QT studies to investigate the extent of QTc errors caused by omitting the correction for QT/RR hysteresis, particularly in small clinical investigations. Statistical modeling approach was used to generate 11,000 simulated samples of 10-subject studies in which mixed effect PK/PD models were used to estimate drug-induced QTc changes at mean maximum plasma concentration of investigated compounds. Calculations of QTc intervals involving and omitting QT/RR hysteresis correction were compared. These comparisons showed that ignoring QT/RR hysteresis has two undesirable effects: (A) In the design of subject-specific heart rate corrections (needed in studies of drugs that change heart rate) omission of QT/RR hysteresis may lead to signals of QTc prolongation of more than 10 ms to be missed. (B) Irrespective of whether the investigated drug changes heart rate, omission of QT/RR hysteresis causes the widths of the confidence intervals of the PK/PD predicted QTc interval changes to be increased by 20–30% on average (exceeding 50% in some cases). This may lead to a failure of excluding meaningful QTc prolongation which would be excluded if using hysteresis correction. The study concludes that correction for QT/RR hysteresis should be incorporated into future studies of drug-induced QTc changes. Subject-specific heart rate corrections that omit hysteresis correction may lead to erroneously biased conclusions. Even when using universal (e.g. Fridericia) heart rate correction, hysteresis correction decreases the confidence intervals of QTc changes and thus helps avoiding false positive outcomes.
引用
收藏
页码:491 / 503
页数:12
相关论文
共 229 条
  • [1] Zhang J(2005)E14 Clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Guidance to industry Fed Regist 70 61134-61135
  • [2] Machado SG(2008)Statistical issues including design and sample size calculation in thorough QT/QTc studies J Biopharm Stat 18 451-467
  • [3] Malik M(2010)Thorough QT studies. Questions and quandaries Drug Saf 33 1-14
  • [4] Garnett CE(2014)Cardiac safety research consortium: can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward Am Heart J 168 262-272
  • [5] Zhang J(2015)Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase Clin Pharm Therap 97 326-335
  • [6] Darpo B(2014)Comparison of automated measurements of electrocardiographic intervals and durations by computer-based algorithms of digital electrocardiographs Am Heart J 167 150-159
  • [7] Garnett C(2006)Precision of QT interval measurement by advanced electrocardiographic equipment Pacing Clin Electrophysiol 29 1277-1284
  • [8] Benson CT(2012)Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effects Am Heart J 163 912-930
  • [9] Keirns J(2013)QT/RR curvatures in healthy subjects: sex differences and covariates Am J Physiol Heart Circ Physiol 305 H1798-H1806
  • [10] Leishman D(2004)Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods Ann Noninvasive Electrocardiol 9 48-57